<?xml version="1.0" encoding="UTF-8"?><html xmlns="http://www.w3.org/1999/xhtml" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:protege="http://protege.stanford.edu/plugins/owl/protege#" xmlns:xsp="http://www.owl-ontologies.com/2005/08/07/xsp.owl#" xmlns:Thesaurus="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:dublincorens="http://purl.org/dc/elements/1.1/"  version="XHTML+RDFa 1.0" ><body>SAGE-Hindawi Access Research <br /> Enzyme Research <br /> Volume 2011, Article ID 518258, 8 pages <br /> doi:10.4061/2011/518258 <br />  <br />  <br />  <br />  <br /> Review Article <br /> Trypanosome Prereplication Machinery: A Potential New <br /> Target Old Problem <br />  <br />           Simone Guedes Calderano, Patricia Diogo Melo Godoy, <br />           Julia Pinheiro Chagas da Cunha, Maria Carolina Elias <br />           Laborat&#194;&#180;orio Especial Toxinologia Aplicada (LETA) Center Applied Toxinology (CAT/CEPID), <br />           Instituto Butantan, Avenida Vital Brasil 1500, 05503-000 S&#203;&#339;ao Paulo, SP, Brazil <br />  <br />           Correspondence addressed Maria Carolina Elias, carol@butantan.gov.br <br />  <br />           Received 15 December 2010; Revised 16 March 2011; Accepted 30 March 2011 <br />  <br />           Academic Editor: Ariel M. Silber <br />  <br />           Copyright &#194;&#169; 2011 Simone Guedes Calderano et al. This open access article distributed Creative Commons <br />           Attribution License, permits unrestricted use, distribution, reproduction medium, provided original work is <br />           properly cited. <br />  <br />           Approximately million people su&#239;&#172;&#8364;er Chagas disease worldwide, caused Trypanosoma cruzi, disease burden <br />           predominately focused Latin America. Sleeping sickness health problem, caused Trypanosoma brucei, <br />           especially sub-Saharan countries. Unfortunately, drugs currently available treat diseases toxic e&#239;&#172;&#8364;ects not <br />           e&#239;&#172;&#8364;ective disease phases parasite strains. Therefore, clear need development novel drugs drug <br />           targets treat diseases. We propose trypanosome prereplication machinery component, Orc1/Cdc6, potential target <br />           drug development. In trypanosomes, Orc1/Cdc6 involved nuclear DNA replication, and, despite involvement such <br />           conserved process, Orc1/Cdc6 distinct mammalian Orc1 Cdc6 proteins. Moreover, RNAi-mediated silencing try- <br />           panosome Orc1/Cdc6 expression T. brucei decreased cell <span id='am-4' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-5' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-6' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-7' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-8' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-9' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-10' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-11' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-12' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-13' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-14' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-15' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-16' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-17' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-18' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-19' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-20' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-21' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-22' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-23' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-24' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-25' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-26' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-27' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-28' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-29' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-30' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-31' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-32' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-33' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-34' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-35' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-36' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-37' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-38' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-39' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-40' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-41' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-42' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-43' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-44' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-45' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-46' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-47' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-48' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-49' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-50' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-51' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-52' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-53' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-54' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-55' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-56' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-57' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-58' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-59' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-60' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-61' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-62' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-63' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-64' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-65' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-66' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-67' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-68' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-69' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-70' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-71' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-72' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-73' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-74' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-75' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-76' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-77' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-78' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-79' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-80' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-81' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span>survival</span>, indicating Orc1/Cdc6 critical trypanosome survival. <br />  <br />  <br /> 1. Introduction                                                           noninfective life cycle stage parasite prolifer- <br />                                                                           ate binary fission guts Triatoma infestans insects, <br /> Currently, approximately million people Chagas                   commonly known kissing bugs. These <br /> disease worldwide, disease burden centered              epimastigotes transform infective metacyclic <br /> Latin America. In 2008, approximately thousand people                 form insect hindgut. Then, insect vector <br /> died disease. Sleeping sickness              bites mammalian host, eliminate metacyclic <br /> health problem, particularly sub-Saharan countries;             parasites feces. This allows parasites penetrate <br /> first half twentieth century, disease practically             wounded skin enter mammalian host&#226;&#8364;&#8482;s <br /> decimated entire communities central Africa [1]. After                 circulatory system. Within bloodstream, metacyclic <br /> many surveillance programs, 2009 marked time                 parasites transform trypomastigotes, infect <br /> 50 years thousand new cases sleeping                mammalian cells transform amastigotes. Amastig- <br /> sickness reported Africa (http://www.who.org/).                   otes spherically shaped proliferate inside infected <br />      The causal agents Chagas disease sleeping sickness            cells transforming nonreplicative trypomastigotes. <br /> are, respectively, protozoan parasites Trypanosoma cruzi              The life cycle completed insect vector bites <br /> and T. brucei Kinetoplastida order. Two subspecies T.           infected mammalian host takes trypomastigotes <br /> brucei, T. b. rhodesiense, T. b. gambiense, responsible           blood transform epimastigotes <br /> for acute sleeping sickness Eastern Southern Africa                inside insect gut. <br /> and chronic sleeping sickness Western Central                          In contrast T. cruzi, life cycle T. brucei spp. <br /> Africa, respectively. Chronic sleeping sickness accounts              entirely extracellular. In case, infected tsetse <br /> approximately 95% reported cases.                                  fly (Glossina genus) bites mammalian host, transferring <br />      These protozoa life cycles alternate             metacyclic trypomastiogte forms circulatory sys- <br /> mammalian host insect host. T. cruzi epimastigotes                 tem. Metacyclic trypomastiogtes transform bloodstream <br />  2                                                                                                                  Enzyme Research <br />  <br /> trypomastigotes proliferate hemolymphatic           numerous e&#239;&#172;&#8364;ects, benznidazole (BNZ) (N-benzyl-2- <br /> system trypomastigotes, slender form; next,          nitroimidazole-1-acetamide) nifurtimox (NF) (4-([5- <br /> the parasites transform non-proliferative form             nitrofurfuryledene]amino)-3-methylthiomorpholine-1,1 <br /> is stumpy appearance. When new tsetse fly bites              dioxide) e&#239;&#172;&#8364;ective Chagas disease. Both were <br /> infected mammalian host, non-proliferative, stumpy             introduced clinical use 1970&#226;&#8364;&#8482;s [12]. While NF <br /> parasites taken fly transform                 increases production free radicals believed cause <br /> proliferating procyclic forms fly midgut. Parasites           trypanosome death [13, 14], BNZ disrupts protein synthesis <br /> then migrate salivary glands insect         respiratory chain T. cruzi (for review [15]). <br /> transform epimastigotes proliferate binary          However, drugs ine&#239;&#172;&#8364;ective chronic phase <br /> fission. Finally, epimastigotes transform infective         disease. In phases Chagas disease, the <br /> metacyclic trypomastigotes, injected           course treatment dependent patient&#226;&#8364;&#8482;s symptoms; <br /> new mammalian host tsetse fly&#226;&#8364;&#8482;s bite.                     medicines surgery recommended patients with <br />      As shown above, Chagas disease transmitted           heart complications, diet changes possibly surgery <br /> the infected feces triatomines, sleeping sickness         suggested patients digestive complications. <br /> is transmitted infected saliva tsetse flies.               <span id='am-3' about='protege:TO' typeof='owl:Thing'>To</span> treat sleeping sickness, medicines currently <br /> However, transmission modes shared                 commonly used. Pentamidine suramin considered <br /> species, include transmission blood transfu-             first-stage drugs. Pentamidine used 1940 and <br /> sions, vertical mother-to-child transmission, acciden-        first-choice drug treat initial stages T. b. <br /> tal infections laboratory.                                    gambiense infection; administered intramuscular <br />      Diagnosis based presentation clinical symp-        injection. The exact antiprotozoal mechanisms action <br /> toms signs, direct parasitological testing blood           pentamidine unknown, acts <br /> cerebrospinal fluids (in case T. brucei infection),           targets including mitochondria DNA <br /> serological tests and/or parasite DNA detection using             (reviewed [16, 17]). Suramin negative charges that <br /> polymerase chain reactions (PCR). To detect T. cruzi PCR,         allow interact electrostatically trypanosomal <br /> samples assayed presence minicircle kinetoplast       enzymes, including enzymes involved glycolysis pen- <br /> DNA 195-bp reiterated DNA sequence [2, 3]. One                 tose phosphate pathway [18]. As resistance suramin <br /> serological test used sleeping sickness diagnosis        observed T. b. gambiense, suramin currently <br /> is card agglutination test trypanosomiasis (CATT);           used cases T. b. rhodesiense infection (for review <br /> it detects T. b. gambiense-specific antibodies [4]. For Chagas       [16]). <br /> disease, T. cruzi-specific antibodies detected                More toxic pentamidine suramin, melarsoprol, <br /> assays using crude recombinant antigens [5, 6].            eflornithine, combination eflornithine NF <br /> However, use serological tests infer Chagas disease        (for melarsoprol-refractory patients) used treat <br /> cure controversial, antibodies parasite antigens       patients neurological phase. Eflornithine, alpha-diflu- <br /> can remain circulation long periods time [7].              oromethylornithine, administered intravenously and <br />      The absence presence mild symptoms associated          infusion irreversible inhibits polyamine biosynthesis <br /> with chronic phases diseases. However, acute         acting ornithine decarboxylase (EC 4.1.1.17). It only <br /> symptoms Chagas disease diagnosed trained             e&#239;&#172;&#8364;ective T. brucei gambiense infections [19]. In spite <br /> physician include swelling, nausea, diarrhea, vomiting,          toxic e&#239;&#172;&#8364;ects, melarsoprol widely used <br /> liver spleen enlargement, fever, headaches, chest          drug second stage sleeping sickness; further, it <br /> abdominal pain. About 40% patients develop chronic                drug available treat T. b. rhodesiense infections. <br /> disease heart colon dilation 10&#226;&#8364;&#8220;20 years            Melarsoprol derived arsenic, believed that <br /> infection. Similarly, sleeping sickness characterized     melarsen oxide active metabolite vivo. Although it <br /> two distinct stages. In acute phase hemolymphatic             unknown melarsoprol kills parasites, parasite lysis <br /> stage, symptoms include headache, malaise, weight loss,              following melarsoprol exposure demonstrated [20]. <br /> fatigue, fever, vomiting. In second phase, known             Although clear need new drugs treat <br /> as neurological phase, parasites present          trypanosome-induced diseases, drugs clinical tri- <br /> cerebral spinal fluid brain cause neurological          als initiated recently. The absence standard <br /> and physiatric symptoms including anxiety, disruption         protocols evaluate drug e&#239;&#172;&#402;cacy absence of <br /> sleep-wake cycle, behavior changes, motor features          clinical parasitological markers contribute di&#239;&#172;&#402;culty of <br /> as muscle tremors walking di&#239;&#172;&#402;culties [8]. If untreated,          launching new treatment initiatives. In case Chagas <br /> sleeping sickness fatal. In absence treatment,       disease, novel drugs toxic e&#239;&#172;&#8364;ects shorter <br /> estimated T. b. gambiense infection fatal       administration times drugs treat chronic disease <br /> years [9] T. b. rhodesiense infection fatal   prioritized. Therefore, standard protocol drug <br /> to months [10, 11].                                            screening acute T. cruzi infections proposed to <br />      Drugs used treat Chagas disease sleeping sickness        evaluate drug e&#239;&#172;&#402;cacy in vitro vivo models <br /> have undesired toxic e&#239;&#172;&#8364;ects e&#239;&#172;&#8364;ective        compared BNZ. Although important evaluate <br /> all parasite life cycle stages parasite strains        e&#239;&#172;&#8364;ect compounds chronic infection, it <br /> drug resistance. However, e&#239;&#172;&#8364;ective drugs exist treat              possible di&#239;&#172;&#402;culty evaluating parasite <br /> the acute phases diseases. Despite presence           clearance using current methods [21]. Most recently, studies <br />  Enzyme Research                                                                                                                    3 <br />  <br /> have focused azolic compounds itraconazole                   ORC1-6 <br />                                                                                                    Orc1/Cdc6 <br /> posaconazole inhibit ergosterol synthesis. In mouse <br /> models, drugs shown cure acute and <br /> chronic Chagas disease [22]. In addition, posaconazole has <br /> activity T. cruzi vivo vivo. <br />     Regarding sleeping sickness, new drugs have <br /> lower toxic e&#239;&#172;&#8364;ects, treat T. b. gambiense T. b. <br /> rhodesiense infections, treat late-stage T. b. rhodesiense                    Cdc6 <br /> infection. Pafuramidine maleate (DB289) new drug in <br /> clinical trial treatment sleeping sickness [23]. How- <br /> ever, cross blood-brain barrier, be <br /> used early stage treatment. Despite this, advan-                                                           Unknow <br />                                                                                                                          protein <br /> tage pentamidine orally administrated.                                                (a)   (b) <br />                                                                                   Cdt1            MCM <br />     As illustrated above, need new drugs novel                               MCM <br /> drug targets treat Chagas disease sleeping <br /> sickness evident. These drugs target fundamental <br /> pathways parasites. In spite conserved <br /> nature essential pathways eukaryotic organisms,                  (A) Mammals                   (B) Trypanosomatids <br /> we identified trypanosome prereplication machinery com- <br /> ponent fundamental replication distinct    Figure 1: Schematic representation prereplication machinery <br /> <span id='am-1' about='protege:FROM' typeof='owl:Thing'>from</span> eukaryotic prereplication machinery; component           mammals (A) trypanosomatids (B). (a) (b) indicate <br />                                                                    possible mechanisms MCM recruitment repli- <br /> is necessary origin selection establishment of <br />                                                                    cation origin. (a) Orc1/Cdc6 recruits MCM complex. (b) An <br /> the DNA replication fork [24]. These data indicate       unknown protein recruits MCM complex replication <br /> enzyme potential drug target treatment        origin. <br /> Chagas disease sleeping sickness. <br />  <br /> 2. Eukaryotic Prereplication Machinery                             Orc1 (see Figure 2). Therefore, Orc1 closely related <br />                                                                    Cdc6 ORC component [30]. <br /> DNA replication eukaryotes begins assembly              Among ORC subunits, Orc1, Orc4, Orc5 belong <br /> the prereplication complex regions chromosomes            AAA+ family, proteins exhibit ATPase activity <br /> known replication origins [25, 26]. The prereplication          function multiple cellular activities [31]. Orc2 and <br /> complex assembly (depicted Figure 1) begins            Orc3 contain ATPase-like domain; Orc6 lacks AAA+ <br /> origin recognition complex (ORC), comprised di&#239;&#172;&#8364;er-          domain shows structural similarity other <br /> ent subunits (Orc1&#226;&#710;&#8217;6 ) [25, 27], recognizes replication        Orc proteins. The AAA+ domain contains Walker A <br /> origins allows recruitment cell division cycle          Walker B motifs regions named sensor 1 and <br /> Cdc6 Cdt1 proteins complex. Together,               sensor 2. These regions typical proteins act as <br /> ORC, Cdc6 Cdt1 proteins recruit mini-chromosome            &#226;&#8364;&#339;Clamp-loaders&#226;&#8364;?, proteins encircle DNA bind other <br /> maintenance (MCM) complex, comprised               factors serve processivity-promoting factors DNA <br /> subunits (Mcm2&#226;&#710;&#8217;7 ); MCM complex harbors helicase           replication ATP-dependent manner. Walker A B <br /> activity essential DNA replication [28]. Once      motifs sensor 1 2 regions responsible ATP <br /> prereplication machinery bound replication origins,      binding hydrolysis [31]; ATP binding hydrolysis <br /> these origins licensed, meaning replication           trigger conformational change ORC allows <br /> process initiate origins binding       serial recruitment proteins prereplication <br /> regulatory factors DNA replication fork components             complex assembly replication origins [32]. <br /> during onset S-phase.                                           Cdc6 (58 KDa S. cerevisiae) isolated from <br />                                                                    thermo-sensitive mutants identified important <br /> 3. Structural Aspects ORC Cdc6                          factor beginning DNA replication [33]. Cdc6 <br />    Prereplication Machinery Components                             AAA+ domain, containing Walker A and <br />                                                                    Walker B motifs sensor 1 2 regions [30]. Similar to <br /> The ORC complex purified S. cerevisiae              Orc1, Cdc6 exhibits intrinsic ATPase activity vitro [34]. <br /> extract proteins bound replication origins [29]. S. <br /> cerevisiae ORC (413 KDa) heterohexamer contains          4. Recruitment Prereplication Machinery <br /> six proteins named according relative molecular mass: <br /> Orc1 (120 KDa), Orc2 (72 KDa), Orc3 (62 KDa), Orc4                 The molecular bases enable recruitment prerepli- <br /> (56 KDa), Orc5 (53 KDa), Orc6 (50 KDa). Orc1&#226;&#710;&#8217;5                 cation machinery described yeast are <br /> orthologs identified wide range organisms,            dependent ATP binding ATP hydrolysis (Figure 3). <br /> suggesting genes present eukaryotic          As mentioned previously, step prereplication <br /> organisms. Of Orcs, Cdc6 notably similar        machinery assembly binding ORC the <br />  4                                                                                                                 Enzyme Research <br />  <br />                                                                                               Orc1Cdc6 tb <br />                                                                                               Orc1Cdc6 tc <br />                                                                                               Orc1Cdc6 lm <br />                                                                                               Cdc6 hs <br />                                                                                               Orc1 hs <br />                                                                                               Orc1Cdc6 mp <br />                                                                                               Orc3 hs <br />                                                                                               Orc5 hs <br />                                                                                               Orc2 hs <br />                                                                                               Orc4 hs <br />                                                                                               Orc6 hs <br />                                  506.9 <br />                                      500     400        300         200        100        0 <br />                                                      Aminoacids substitution              &#195;&#8212;102 <br />  <br />  <br /> Figure 2: Phylogenetic tree human Orc1 Orc6, human Cdc6, Orc1/Cdc6 Trypanosoma cruzi (Orc1Cdc6 tc), Trypanosoma <br /> brucei (Orc1Cdc6 tb), Leishmania major (Orc1Cdc6 lm), Methanoplanus petrolearius (orc1Cdc6 Mp), Archaea species. The <br /> phylogenetic tree generated using ClustalW alignment method. <br />  <br />  <br />  <br />                  ATP                                                   occur [36]. Therefore, ATPase activity ORC <br />                                                                        Cdc6 work select specific replication origins. <br />      ORC <br />                                                                            Once bound DNA, ORC Cdc6 able to <br />          &#226;&#710;&#8212;                   Specific                                  interact Cdt1, brings MCM complex the <br />                         replication origin                             replication origin. At moment, low activity the <br />                                                                        Cdc6 ATPase important establish ORC-Cdc6-DNA <br />                                                                        interaction required recruit MCM complex <br />                                                                        replication origins (reviewed [37]). After MCM <br />           &#226;&#710;&#8212;                                                            complex recruitment, Orc1 ATPase enables MCM-DNA <br />                  Cdc6                           ORC ATPase             interaction [38]. Once MCM complex recruited and <br />                                                  activity              established replication origins, ORC, Cdc6 and <br />                                                                        Cdt1 need bound replication origin sites <br />                                                                        longer. At point, prior activation DNA <br />                                                                        replication, proteins disassociate replication <br />                MCM <br />                                                                        origins ATPase-dependent manner [39]. <br />                                                                            These data clearly demonstrate extreme importance <br />                                                    ADP                 ATPase activities di&#239;&#172;&#8364;erent components the <br />                         Cdt1 <br />                                                                        prereplication machinery stabilization assembly of <br />                                                                        prereplication machinery DNA replication origins. <br />                                Cdc6 ATPase <br />                                  activity                              In selection replication origins, assembly of <br />                                                                        prereplication complex replication origins, the <br /> Figure 3: Schematic representation prereplication machinery         recruitment MCM helicase, dissociation <br /> recruitment. Figure 3 shows Cdc6 ORC ATPase activities        prereplication complex replication origins to <br /> are important release molecules complex.     avoid new round DNA replication cell cycle, <br /> Asterisks steps ORC ATPase activity (purple &#226;&#710;&#8212;) or <br />                                                                        balance high low ATPase activity critical <br /> Cdc6 ATPase activity (orange &#226;&#710;&#8212;) important prevention <br /> of assembly prereplication machinery nonspecific <br />                                                                        precise DNA replication. <br /> replication origins. <br />                                                                        5. Trypanosome Orc1/Cdc6: The <br />                                                                           Prereplication Machinery Component <br /> replication origins, step depends binding                Its ATPase Activity <br /> the ORC ATP. ORC-double-stranded DNA interactions <br /> are specific inhibit ATPase activity ORC. In            Although eukaryotic cells, trypanosomes prereplica- <br /> this way, high ATPase activity ORC inhibits stable          tion machinery component di&#239;&#172;&#8364;erent eukary- <br /> ORC interactions nonspecific DNA. However,                 otes instead closer Archaea species. Genomic <br /> presence specific replication origin, ATPase activity         databases trypanosomatids organisms <br /> of ORC inhibited, undergoes conformational             contain sequences genome <span id='am-2' about='Thesaurus:code' typeof='owl:Thing'>code</span> for <br /> change; conformation change stabilizes ORC-DNA                 Orc1&#226;&#8364;&#8220;Orc6 subunits, Cdc6 Cdt1. Additionally, several <br /> interaction allows ORC bind Cdc6 (reviewed               Archaea sp. copies proteins that <br /> [35]). The stability ORC-Cdc6-DNA interactions              exhibit high sequence homology Orc1 Cdc6; <br /> regulated ATPase activity Cdc6, high             proteins called Orc1/Cdc6 proteins [40&#226;&#8364;&#8220;42] <br /> the presence nonspecific DNA, destabilizing complex             (Figure 2). Trypanosomatids annotated gene only <br /> [34]. ORC-Cdc6-DNA interactions trigger conformational               subunits ORC, Orc1, also <br /> alteration Cdc6 allows Cdc6-Cdt1 interaction           homologous Cdc6. It annotated Orc1 [43] and <br />  Enzyme Research                                                                                                                    5 <br />  <br />  <br />  <br />                                   AAA+ <br />  <br />                                                          WH <br />  <br />  <br />  <br />  <br />                                           (a)                                         (b) <br />  <br /> Figure 4: (a) Shows archaea Orc1/Cdc6 structure ATP. The AAA+ WH domains indicated. (b) Shows predicted <br /> structure T. cruzi Orc1/Cdc6, obtained using 3D-PSSM program (http://www.sbg.bio.ic.ac.uk/&#226;&#710;&#188;3dpssm/index2.html). <br />  <br />  <br />  <br />  <br /> we named Orc1/Cdc6. In TIGR Parasites Database               Orc1/Cdc6. Alternatively, prereplication machinery <br /> (http://www.tigr.org/), sequences annotated             assembled unknown protein bind <br /> Orc1 (Tc00.1047053511159.20 Tc1047053508239.10)              Orc1/Cdc6 recruit MCM complex replica- <br /> the genome T. cruzi (representing gene alleles). Single          tion origins. This assembly scheme depicted Figure 1(b). <br /> sequences annotated Orc1 genomes T. brucei        It important note studies confirm if <br /> (Tb11.02.5110) T. brucei gambiense (Tbg972.11.8220).            schematic representation correct. Recently, group <br /> The Orc1 protein sequences T. cruzi 98.2%              Dr. Richard McCulloch identified further <br /> identical. The Orc1sequences T. cruzi T. brucei        ORC-like factor (pers comm.) T. brucei. Further studies <br /> 77.1% 77.8% identical. Trypanosome Orc1/Cdc6                conducted determine Orc1/Cdc6 ATPase <br /> confirmed prereplication machinery component           activity important assembly prereplication <br /> it replaced yeast Cdc6 yeast phenotypic complementa-           machinery release prereplication <br /> tion assay; further, silencing trypanosome Orc1/Cdc6         complex proteins replication origins. Nevertheless, <br /> expression <span id='am-160' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-161' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-162' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-163' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-164' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-165' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-166' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-167' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-168' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-169' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-170' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-171' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-172' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-173' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-174' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-175' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-176' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-177' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-178' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-179' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-180' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-181' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-182' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-183' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-184' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-185' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-186' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-187' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-188' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-189' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-190' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-191' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-192' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-193' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-194' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-195' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-196' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-197' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-198' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-199' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-200' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-201' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-202' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-203' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-204' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-205' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-206' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-207' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-208' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-209' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-210' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-211' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-212' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-213' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-214' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-215' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-216' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-217' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-218' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-219' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-220' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-221' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-222' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-223' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-224' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-225' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-226' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-227' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-228' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-229' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-230' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-231' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-232' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-233' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-234' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-235' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-236' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-237' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span>RNA interference</span> T. brucei impaired nuclear        silencing trypanosome Orc1/Cdc6 expression RNAi <br /> DNA replication [24].                                               T. brucei negative a&#239;&#172;&#8364;ected <span id='am-82' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-83' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-84' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-85' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-86' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-87' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-88' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-89' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-90' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-91' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-92' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-93' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-94' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-95' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-96' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-97' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-98' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-99' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-100' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-101' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-102' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-103' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-104' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-105' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-106' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-107' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-108' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-109' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-110' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-111' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-112' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-113' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-114' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-115' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-116' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-117' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-118' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-119' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-120' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-121' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-122' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-123' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-124' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-125' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-126' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-127' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-128' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-129' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-130' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-131' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-132' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-133' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-134' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-135' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-136' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-137' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-138' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-139' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-140' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-141' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-142' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-143' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-144' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-145' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-146' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-147' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-148' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-149' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-150' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-151' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-152' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-153' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-154' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-155' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-156' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-157' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-158' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-159' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span>cell survival</span> [24]. This data <br />      Analyses structural alignment using Phyre server,     strongly indicates Orc1/Cdc6 extremely important for <br /> web-based method protein folding recognition, showed            trypanosome survival identifies Orc1/Cdc6 potential <br /> a higher structural similarity trypanosome Orc1/Cdc6             target drug design. <br /> to archaea Orc1/Cdc6 [24]. Also, analyses predicted <br /> tridimensional structure T. cruzi Orc1/Cdc6 3D-               6. ATPase Activity Inhibitors <br /> PSSM (http://www.sbg.bio.ic.ac.uk/&#226;&#710;&#188;3dpssm/index2.html), <br /> which determines probable folds based               Di&#239;&#172;&#8364;erent proteins harboring ATPase activity being <br /> occurrence motifs present secondary structure,            studied potential drug targets inhibition of <br /> showed probable structural T. cruzi Orc1/Cdc6           ATPase activity [46&#226;&#8364;&#8220;49]. The inhibition ATPase <br /> is homologous Archaea Orc1/Cdc6 (Figure 4). These                activity heat-shock protein 90 (HSP90) main target <br /> analyses suggest trypanosome Orc1/Cdc6 closer            cancer treatment. HSP90 chaperone acts the <br /> Archaea prereplication machinery mammalian pre-             folding, stabilization, assembly proteins that <br /> replication machinery. Primary sequences trypanosome             involved biological processes [50, 51]; further, <br /> Orc1/Cdc6 contain Walker A B motifs, related            responsible maintenance cancer cells by <br /> ATP/GTP binding, sensor 1 2 regions                facilitating function oncoproteins allowing malignant <br /> involved ATP hydrolysis; features typical           transformation [52]. Because HSP90 tumor cells has <br /> prereplication machinery components exhibit AAA+           higher activity compared HSP90 normal cells <br /> ATPase fold [44, 45]. In fact, T. cruzi T. brucei          [53], inhibition e&#239;&#172;&#8364;ects tumor cells higher in <br /> Orc1/Cdc6 exhibit ATPase activity, which, presence        normal cells [53], making HSP90 good target drug <br /> increased concentrations ATP follows Michaelis-Menten          design [46, 54]. Geldanamycin, natural compound, the <br /> (MM) kinetic model. This ATPase activity increases           compound described antitumor e&#239;&#172;&#8364;ects the <br /> presence nonspecific DNA [24], suggesting that, similar          inhibition HSP90 ATPase activity [55&#226;&#8364;&#8220;57]. Geldanamycin <br /> to yeast, trypanosome Orc1/Cdc6 ATPase activity               binds N-terminal ATP-binding pocket HSP90, <br /> be involved selection specific replication origins.       blocking ATPase activity [58]. Since findings <br /> As mentioned previously, Cdt1 homologous                reported, studies focused HSP90 as <br /> protein trypanosomatid genome database. Therefore,           target, drugs 17-DMGA (alvespimycin) <br /> in organisms, prereplication machinery              17-AAG/tanespimycin reached phase I phase II <br /> be assembled recruitment MCM complex                  clinical trials, respectively [46]. <br />  6                                                                                                                    Enzyme Research <br />  <br />     Another important health problem antibiotic resis-         References <br /> tance treatment bacterial infections [59]. Di&#239;&#172;&#8364;erent <br /> proteins ATPase activity targeted high-         [1] J. Pepin, &#226;&#8364;&#339;Combination therapy sleeping sickness: wake- <br />                                                                        call,&#226;&#8364;? Journal Infectious Diseases, vol. 195, no. 3, pp. 311&#226;&#8364;&#8220; <br /> throughput screening order new inhibitors with <br />                                                                        313, 2007. <br /> potential antibiotic e&#239;&#172;&#8364;ects. Bacterial RecA [60], DNA gyrase <br />                                                                    [2] G. Russomando, M. M. C. De Tomassone, I. De Guillen et <br /> [48], essential replicative DNA helicase [49] of <br />                                                                        al., &#226;&#8364;&#339;Treatment congenital chagas&#226;&#8364;&#8482; disease diagnosed and <br /> the ATPase proteins e&#239;&#172;&#8364;ort concentrated.            followed polymerase chain reaction,&#226;&#8364;? American <br /> RecA bacterial protein involved DNA repair,              Journal Tropical Medicine Hygiene, vol. 59, no. 3, pp. <br /> interacts single-stranded DNA ATPase              487&#226;&#8364;&#8220;491, 1998. <br /> activity allows recombinational DNA repair            [3] A. R. Vago, L. O. Andrade, A. A. Leite et al., &#226;&#8364;&#339;Genetic <br /> horizontal gene transfer, processes essential         characterization Trypanosoma cruzi directly tissues of <br /> acquisition drug resistance genes [47]. Inhibitors RecA          patients chronic chagas disease: di&#239;&#172;&#8364;erential distribution <br /> ATPase activity act binding ATP-binding site               genetic types diverse organs,&#226;&#8364;? American Journal of <br /> are screened, indicating potential development            Pathology, vol. 156, no. 5, pp. 1805&#226;&#8364;&#8220;1809, 2000. <br /> antibiotics capable preventing bacterial drug resistance        [4] E. Magnus, T. Vervoort, N. Van Meirvenne, &#226;&#8364;&#339;A card- <br /> [60].                                                                  agglutination test stained trypanosomes (C.A.T.T.) for <br />     DNA gyrase replicative DNA helicase                    serological diagnosis T. b. gambiense trypanosomiasis,&#226;&#8364;? <br /> proteins involved bacterial DNA replication                 Annales la Societe Belge Medecine Tropicale, vol. 58, no. 3, <br />                                                                        pp. 169&#226;&#8364;&#8220;176, 1978. <br /> essential bacterial survival. Both ATPase activity <br /> indispensable function [48]. DNA gyrase type        [5] E. S. Umezawa, S. F. Bastos, M. E. Camargo et al., &#226;&#8364;&#339;Evaluation <br />                                                                        recombinant antigens serodiagnosis Chagas&#226;&#8364;&#8482; disease <br /> II topoisomerase capable introducing negative supercoils <br />                                                                        South Central America,&#226;&#8364;? Journal Clinical Microbiol- <br /> during DNA replication. Although comprised                ogy, vol. 37, no. 5, pp. 1554&#226;&#8364;&#8220;1560, 1999. <br /> subunits (A B), B subunit ATPase activity. The <br />                                                                    [6] A. C. Pastini, S. R. Iglesias, V. C. Carricarte, M. E. Guerin, D. O. <br /> aminocoumarin antibiotic class, novobiocin (4-              Sanchez, A. C. Frasch, &#226;&#8364;&#339;Immunoassay recombinant <br /> Hydroxy-3-[4-hydroxy-3-(3-methylbut-2-enyl)benzamido]-                 Trypanosoma cruzi antigens potentially useful screening <br /> 8-methylcoumarin-7-yl3-O-carbamoyl-5,5-di-C-methyl-                    donated blood diagnosing Chagas disease,&#226;&#8364;? Clinical <br /> &#206;&#177;-l-lyxofuranoside) licensed treatment human                 Chemistry, vol. 40, no. 10, pp. 1893&#226;&#8364;&#8220;1897, 1994. <br /> infections, binds B subunit inhibiting ATP              [7] M. S. Leguizamon, &#194;&#180; G. Russomando, A. Luquetti et al., &#226;&#8364;&#339;Long- <br /> hydrolysis required DNA supercoiling preventing                lasting antibodies detected trans-sialidase inhibition <br /> cell growth [48]. The DNA replicative helicase, DNA B,              assay sera parasite-free, serologically cured chagasic <br /> responsible opening double-stranded DNA ATP                patients,&#226;&#8364;? Journal Infectious Diseases, vol. 175, no. 5, pp. <br /> hydrolysis, makes DNA available replication           1272&#226;&#8364;&#8220;1275, 1997. <br /> machinery duplication bacterial genome. Two         [8] A. J. Duggan M. P. Hutchinson, &#226;&#8364;&#339;Sleeping sickness in <br /> compounds, flavonoid myricetin triaminotriazine,               Europeans: review 109 cases,&#226;&#8364;? Journal Tropical Medicine <br /> able inhibit ATPase activity DNA B helicase               Hygiene, vol. 69, no. 6, pp. 124&#226;&#8364;&#8220;131, 1966. <br /> Escherichia coli Pseudomonas aeruginosa, respectively,         [9] F. Checchi, J. A. N. Filipe, D. T. Haydon, D. Chandramohan, <br /> preventing cell growth [49]. However, drugs                   F. Chappuis, &#226;&#8364;&#339;Estimates duration early and <br /> exhibit cytotoxicity mammalian cell culture,            late stage gambiense sleeping sickness,&#226;&#8364;? BMC Infectious <br /> inhibitors screened possible drug candidates              Diseases, vol. 8, article 16, 2008. <br /> [49].                                                             [10] M. Odiit, F. Kansiime, J. C. K. Enyaru, &#226;&#8364;&#339;Duration of <br />                                                                        symptoms case fatality sleeping sickness caused by <br />     As discussed above, inhibitors ATPase activity              Trypanosoma brucei rhodesiense Tororo, Uganda,&#226;&#8364;? East <br /> being studied possible drugs candidates; some,              African Medical Journal, vol. 74, no. 12, pp. 792&#226;&#8364;&#8220;795, 1997. <br /> novobiocin, used human treat-          [11] E. M. F`evre, P. G. Coleman, S. C. Welburn, I. Maudlin, <br /> ment. This raises possibility searching specific in-        &#226;&#8364;&#339;Reanalyzing 1900&#226;&#8364;&#8220;1920 sleeping sickness epidemic in <br /> hibitors T. brucei T. cruzi Orc1/Cdc6, proteins        Uganda,&#226;&#8364;? Emerging Infectious Diseases, vol. 10, no. 4, pp. 567&#226;&#8364;&#8220; <br /> do closely related protein humans.                       573, 2004. <br />                                                                   [12] J. C. P. Dias, &#226;&#8364;&#339;The treatment Chagas disease (South <br />                                                                        American trypanosomiasis),&#226;&#8364;? Annals Internal Medicine, vol. <br /> 7. Final Considerations                                                144, no. 10, pp. 772&#226;&#8364;&#8220;774, 2006. <br />                                                                   [13] R. Docampo S. N. J. Moreno, &#226;&#8364;&#339;Free radical metabolism <br /> In addition indispensable role DNA replica-                antiparasitic agents,&#226;&#8364;? Federation Proceedings, vol. 45, no. 10, <br /> tion initiator, ORC known a&#239;&#172;&#8364;ect diverse cell                 pp. 2471&#226;&#8364;&#8220;2476, 1986. <br /> processes including chromosome segregation, cytokinesis,          [14] B. Enanga, M. R. Ariyanayagam, M. L. Stewart, M. P. <br /> cell cycle regulation, gene expression [61]. It             Barrett, &#226;&#8364;&#339;Activity megazol, trypanocidal nitroimidazole, <br /> time analyze trypanosome Orc1/Cdc6,                 associated DNA damage,&#226;&#8364;? Antimicrobial Agents and <br /> ATPase activity involved non-DNA replication               Chemotherapy, vol. 47, no. 10, pp. 3368&#226;&#8364;&#8220;3370, 2003. <br /> functions. If so, better justify additional e&#239;&#172;&#8364;orts       [15] W. Apt, &#226;&#8364;&#339;Current developing therapeutic agents the <br /> to search ATPase inhibitor trypanosome                  treatment Chagas disease,&#226;&#8364;? Drug design, development and <br /> Orc1/Cdc6.                                                             therapy, vol. 4, pp. 243&#226;&#8364;&#8220;253, 2010. <br />  Enzyme Research                                                                                                                              7 <br />  <br /> [16] M. P. Barrett, D. W. Boykin, R. Brun, R. R. Tidwell,            [34] C. Speck B. Stillman, &#226;&#8364;&#339;Cdc6 ATPase activity regu- <br />      &#226;&#8364;&#339;Human African trypanosomiasis: pharmacological re-                      lates ORC&#194;&#183;Cdc6 stability selection specific DNA <br />      engagement neglected disease,&#226;&#8364;? British Journal                 sequences origins DNA replication,&#226;&#8364;? Journal Biological <br />      Pharmacology, vol. 152, no. 8, pp. 1155&#226;&#8364;&#8220;1171, 2007.                      Chemistry, vol. 282, no. 16, pp. 11705&#226;&#8364;&#8220;11714, 2007. <br /> [17] B. J. Berger, N. S. Carter, A. H. Fairlamb, &#226;&#8364;&#339;Polyamine          [35] M. Lei B. K. Tye, &#226;&#8364;&#339;Initiating DNA synthesis: from <br />      pentamidine metabolism African trypanosomes,&#226;&#8364;? Acta                recruiting activating MCM complex,&#226;&#8364;? Journal Cell <br />      Tropica, vol. 54, no. 3-4, pp. 215&#226;&#8364;&#8220;224, 1993.                            Science, vol. 114, no. 8, pp. 1447&#226;&#8364;&#8220;1454, 2001. <br /> [18] S. Hanau, M. Rippa, M. Bertelli, F. Dallocchio, M. P. Bar-      [36] S. Chen, M. A. De Vries, S. P. Bell, &#226;&#8364;&#339;Orc6 required <br />      rett, &#226;&#8364;&#339;6-Phosphogluconate dehydrogenase Trypanosoma                 dynamic recruitment Cdt1 repeated Mcm2&#226;&#710;&#8217;&#226;&#710;&#8217;7 <br />      brucei. Kinetic analysis inhibition trypanocidal drugs,&#226;&#8364;?          loading,&#226;&#8364;? Genes Development, vol. 21, no. 22, pp. 2897&#226;&#8364;&#8220; <br />      European Journal Biochemistry, vol. 240, no. 3, pp. 592&#226;&#8364;&#8220;599,          2907, 2007. <br />      1996.                                                               [37] C. Evrin, P. Clarke, J. Zech et al., &#226;&#8364;&#339;A double-hexameric <br /> [19] C. Burri R. Brun, &#226;&#8364;&#339;Eflornithine treatment                 MCM2-7 complex loaded origin DNA licensing <br />      human African trypanosomiasis,&#226;&#8364;? Parasitology Research, vol.              eukaryotic DNA replication,&#226;&#8364;? Proceedings National <br />      90, no. 1, pp. S49&#226;&#8364;&#8220;S52, 2003.                                            Academy Sciences United States America, vol. 106, <br /> [20] S. R. Meshnick, R. W. Grady, S. H. Blobstein, A. Cerami,             no. 48, pp. 20240&#226;&#8364;&#8220;20245, 2010. <br />      &#226;&#8364;&#339;Porphyrin-induced lysis Trypanosoma brucei: role          [38] J. C. W. Randell, J. L. Bowers, H. K. Rodr&#194;&#180;&#196;&#177;guez, S. P. Bell, <br />      zinc,&#226;&#8364;? Journal Pharmacology Experimental Therapeutics,            &#226;&#8364;&#339;Sequential ATP hydrolysis Cdc6 ORC directs loading <br />      vol. 207, no. 3, pp. 1041&#226;&#8364;&#8220;1050, 1978.                                    Mcm2&#226;&#710;&#8217;7 helicase,&#226;&#8364;? Molecular Cell, vol. 21, no. 1, pp. 29&#226;&#8364;&#8220; <br /> [21] A. J. Romanha, S. L. Castro, M. N. C. Soeiro et al., &#226;&#8364;&#339;In              39, 2006. <br />      vitro vivo experimental models drug screening            [39] V. Tsakraklides S. P. Bell, &#226;&#8364;&#339;Dynamics pre-replicative <br />      development Chagas disease,&#226;&#8364;? Memorias Instituto               complex assembly,&#226;&#8364;? Journal Biological Chemistry, vol. 22, pp. <br />      Oswaldo Cruz, vol. 105, no. 2, pp. 233&#226;&#8364;&#8220;238, 2010.                        877&#226;&#8364;&#8220;884, 2010. <br /> [22] A. Liendo, K. Lazardi, J. A. Urbina, &#226;&#8364;&#339;In-vitro antiprolifera- <br />                                                                          [40] M. De Felice, L. Esposito, B. Pucci et al., &#226;&#8364;&#339;Modular organiza- <br />      tive e&#239;&#172;&#8364;ects mechanism action bis-triazole D0870 <br />                                                                               tion Cdc6-like protein crenarchaeon Sulfolobus <br />      $(-) enantiomer Trypanosoma cruzi,&#226;&#8364;? Journal of <br />                                                                               solfataricus,&#226;&#8364;? Biochemical Journal, vol. 381, no. 3, pp. 645&#226;&#8364;&#8220;653, <br />      Antimicrobial Chemotherapy, vol. 41, no. 2, pp. 197&#226;&#8364;&#8220;205, 1998. <br />                                                                               2004. <br /> [23] J. H. Ansede, M. Anbazhagan, R. Brun, J. D. Easterbrook, J. <br />                                                                          [41] M. De Felice, L. Esposito, B. Pucci, M. De Falco, M. Rossi, and <br />      E. Hall, D. W. Boykin, &#226;&#8364;&#339;O-alkoxyamidine prodrugs of <br />                                                                               F. M. Pisani, &#226;&#8364;&#339;A CDC6-like factor archaea Sulfolobus <br />      furamidine: vitro transport microsomal metabolism as <br />                                                                               solfataricus promotes binding mini-chromosome main- <br />      indicators vivo e&#239;&#172;&#402;cacy mouse model Trypanosoma <br />                                                                               tenance complex DNA,&#226;&#8364;? Journal Biological Chemistry, vol. <br />      brucei rhodesiense infection,&#226;&#8364;? Journal Medicinal Chemistry, <br />                                                                               279, no. 41, pp. 43008&#226;&#8364;&#8220;43012, 2004. <br />      vol. 47, no. 17, pp. 4335&#226;&#8364;&#8220;4338, 2004. <br /> [24] P. D. De Melo Godoy, L. A. Nogueira-Junior, L. S. Paes et           [42] M. De Felice, L. Esposito, M. Rossi, F. M. Pisani, &#226;&#8364;&#339;Bio- <br />      al., &#226;&#8364;&#339;Trypanosome prereplication machinery contains single             chemical characterization Cdc6/ORC1-like proteins <br />      functional Orc1/Cdc6 protein, typical archaea,&#226;&#8364;?              crenarchaeon Sulfolobus solfataricus,&#226;&#8364;? Extremophiles, <br />      Eukaryotic Cell, vol. 8, no. 10, pp. 1592&#226;&#8364;&#8220;1603, 2009.                    vol. 10, no. 1, pp. 61&#226;&#8364;&#8220;70, 2006. <br /> [25] S. P. Bell A. Dutta, &#226;&#8364;&#339;DNA replication eukaryotic cells,&#226;&#8364;?     [43] N. M. El-Sayed, P. J. Myler, D. C. Bartholomeu et al., &#226;&#8364;&#339;The <br />      Annual Review Biochemistry, vol. 71, pp. 333&#226;&#8364;&#8220;374, 2002.               genome sequence Trypanosoma cruzi, etiologic agent of <br /> [26] B. Stillman, &#226;&#8364;&#339;Origin recognition chromosome cycle,&#226;&#8364;?              chagas disease,&#226;&#8364;? Science, vol. 309, no. 5733, pp. 409&#226;&#8364;&#8220;415, 2005. <br />      FEBS Letters, vol. 579, no. 4, pp. 877&#226;&#8364;&#8220;884, 2005.                   [44] J. E. Walker, M. Saraste, M. J. Runswick, N. J. Gay, <br /> [27] J. F. X. Di&#239;&#172;&#8222;ey, &#226;&#8364;&#339;DNA replication: building perfect switch,&#226;&#8364;?          &#226;&#8364;&#339;Distantly related sequences alpha- beta-subunits <br />      Current Biology, vol. 11, no. 9, pp. R36 <br /> </body></html>